FARVET

FARVET is a leading Peruvian biopharmaceutical company specializing in the research, development, and manufacture of veterinary biological and pharmaceutical products. Founded in 1983 and headquartered in Chincha, the company is a major provider of vaccines for the poultry and swine industries across Latin America. FARVET gained international attention during the COVID-19 pandemic for its efforts to develop a low-cost, intranasal/oral vaccine for human use based on viral vector technology. The company maintains advanced molecular biology laboratories and focuses on innovative solutions for animal health and emerging zoonotic diseases. Their business model integrates high-level R&D with large-scale manufacturing capabilities.